Source high-purity Omarigliptin, a potent, long-acting DPP-4 inhibitor designed for the once-weekly management of type 2 diabetes. This advanced pharmaceutical intermediate offers superior stability and patient compliance benefits, making it an ideal choice for manufacturers developing next-generation antidiabetic formulations. Secure reliable supply for your R&D and production needs. High-quality raw material. Get a quote today!